Carnitine was determined radioenzymatically in the plasma of 415 hospital employees involved in a screening programme for prevention of major cardiovascular risks. A reference population (N = 340) was extracted after excluding subjects with hypertension, diabetes mellitus or treatment for hypercholesterolaemia. This population showed a Gaussian distribution for total and free carnitine concentrations both in females and males but not for acyl carnitine or the acyl/free ratio. Females had lower total and free carnitine concentrations but a higher ratio of acyl/free carnitine than males. These differences were not detectable in older subjects (35 years for the acyl/free ratio, 45 years for total and free carnitine concentrations). Females with a body mass index > 28 had a lower acyl/free ratio than their respective controls. The differences in carnitine concentrations indicate that sex and age should be matched in patients or experimental groups and controls in studies involving carnitine plasma concentrations.
Introduction
_ ,,.,,, . · · ι Published data on carnitine concentrations in normal Carnitine (3-hydroxy-4-trimethylaminobutanoate) is adult subjects comprise only small sample populations required for the transport of long chain acyl moieties (14) . We therefore took the opportunity to study the into the mitochondria, and for buffering the intra-plasma carnitine concentrations in a cohort of 415 mitochondrial acyl-CoA/CpA ratio (1). Carnitine de-female and male hospital employees freely attending ficiency either results from primary genetic defects or the hospital prevention centre during a screening profrom other genetic or acquired disorders, drug treat-gramme for the detection of the major risk factors ments (including diet) or treatment leading to carni-for cardiovascular disease. The aim of this study was tine loss (2 -7) . Severe carnitine deficiency may result to determine carnitine concentrations in a reference in myopathy (including cardiomyopathy), hepatic en-population for ambulatory patients in dependence on cephalopathy and lipid storage in liver and muscle. age and sex. Hypercarnitinaemia has been described in some patients with liver cirrhosis (8 -10) , in undialysed pa-M t * Is tients with chronic renal insufficiency (11) and in patients treated with lipid lowering drugs (12) , or in £Caraitin.
, , . j ' . . , . " . (Buchs, Switzerland); acetyl-Co A (tnhthium salt) and carnitine rare congenital disorders like carnitine palmitoyl a cetyl transferase (EC 2.3.1.7) from Boehringer Mannheim transferase 1 ) deficiency (13) .
(Rotkreuz, Switzerland). N-Ethylmaleimide, HEPES (2-[4-(hydroxyethyl)-piperazinylj-(l)-ethansulphonic acid) and the ion exchange resin DOWEX 2X8, 200-400 mesh, in the Cl~ form κ £ were from Merck (Zurich Switzerland).
Carnitine acetyl-transferase (EC 2.3.1.7)
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Methods

Subjects
Subjects were hospital employees participating in a screening programme for the detection of major risk factors for ischaemic heart diseases (Lausanne, CHUV, Switzerland, 8-28 November 1990) organized in our university hospital. They arrived independently at the centre between 11 am and 8pm. Fasting was not a prerequisite.
Informed consent was obtained from each subject before blood sampling. The study was approved by the local ethical committee.
Collection of specimens
Blood samples (2.7 ml) were drawn from an antecubital vein after a 10 minutes rest, into lithium heparinate tubes (Sarstedt AG, Sevelen, Switzerland) in the sitting position. Blood was centrifuged, and the plasma was frozen at -80°C within 4 hours after sampling.
Samples (415 out of 1397) were randomly assigned for carnitine determination.
Assays and statistics
Free carnitine was determined in the thawed plasma according to a modified radioenzymatic method (15) O by weight) was then added, the mixture vortexed 20 seconds and placed on ice to improve reproducibility. Mixing was repeated twice at 5 min intervals. After centrifugation (4 °C, 10 rain, 8000 g), 300 μΐ of the supernatant was added to 10 ml of Aquasol (Dupont International S.A) and assayed for radioâ ctivity in a liquid scintillation counter (Tricarb 2500, Canberra Packard, Switzerland). A blank was run in parallel for correction of non-specific supernatant radioactivity.
Total carnitine (free and esterified) was determined as described above except that 500 μΐ of the prediluted sample (1/10, by vol.) was added to 100 μΐ 0.6 mol/1 KOH and allowed to stand at 56 °C for 1 hour. pH was adjusted to 6.7 with 0.5 mmol/1 HC1 and HEPES 2.5 mol/1 pH 6.7. The total carnitine concentration of the sample was calculated from the standard curve of free carnitine, taking into account the dilution. Acylcarnitine concentration was calculated from the difference of total and free carnitine. The acyl to free ratio (acyl/free) was calculated as mol/mol.
Intraserial imprecision (N = 8) was 2.7% and 1.8% for total (57 μπιοΐ/ΐ) and free (43 μηιοΐ/ΐ) carnitine, respectively. Coefficients of variation of the day to day imprecision were assessed with pools of serum and were less than 7% for total and free carnitine.
Other clinical chemistry quantities were assayed on a Hitachi 717 (Boehringer, Rotkreuz, Switzerland) according to the recommendations of the Swiss Society of Clinical Chemistry or IFCC, the enzyme activities being measured at 37 °C.
The body mass index was calculated as weight
The distribution pattern was assessed by comparing the group frequencies with the theoretical Gaussian or log-normal distribution with the Kolmogorov Smirnov and the χ 2 tests. Comparisons between groups were made with the Mann-Whitney test, and correlations were tested with the Spearman rank correlation test.
Results
Samples were analysed from 180 females and 160 males; none was hypertensive or diabetic, and none was receiving treatment for hypercholesterolaemia.
In both sexes, the total and free carnitine concentrations were compatible with a Gaussian distribution (figs. 1 and 2); acyl carnitine and the acyl/free ratio differed significantly from this distribution. The acyl/ free ratio could be normalised by the log transformation in the males only. Thus percentiles and nonparametric tests were used for evaluating these quantities. Mean values for total and free carnitine were significantly higher in the males than in the females. Females had significantly higher median values for acyl carnitine and acyl/free ratio than males (tab. 1). Total and free carnitine tended to increase with age in both sexes. No age effect was observed on acyl carnitine or on the acyl/free ratio in both sexes (tab. 2). Before 45 years of age total carnitine levels were found to be lower in females than in males (tab. 2). The same is true for free carnitine. No more differences were observed after this age. The acyl/free ratio was higher in females than in males whatever the age, but the differences were statistically significant only before the age of 35 years.
In the females, total and free carnitine was lower in the group with a body mass index < 28 [Ml] (N = 157, 34% > 44 years of age) than in the group with a body mass index > 28 [M2] (N = 23, 43% > 44 years of age): median total carnitine, Ml = 38 andM2 = 42μιηο1/1,ρ < 0.01; median free carnitine, Ml = 30 and M2 = 37 μιηοΐ/l, ρ < 0.001. The median acyl/free ratio was lower in the group with a body mass index > 28 (0.15) than in the group with a body mass index < 28 (0.20), ρ < 0.005. These differences cannot be explained by difference in group age. No such differences were seen in the male groups.
Among the frequently assayed clinical chemistry components (aspartate aminotransferase, alandne aminotransferase, lactate dehydrogenase, creatine kinase, γ-glutamyl-transferase, alkaline phosphatase, biUrubin (direct and total), lipase, amylase, albumin, iron, uric acid, urea and creatinine) only a few significant correlations with the carnitine concentrations were found. Significant Spearman rank correlation coefficients did not exceed 0.24 except for the correlation of uric acid with free (0.41) and total (0.41) carnitine in normouricaemic females. Tab. 2. Carnitine concentrations and age: Percentiles for carnitine concentrations and acyl/free ratio in females and males according to age. N = number of specimens; Min = minimal value; Max = maximal value; P2.5 = 2.5 th peicentile; P97.5 = 97.5* percentile; ρ = significance of the Mann-Whitney test between corresponding female and male groups; SD = standard deviation. Male participants with cholesterol values below 6.5 mmol/1 (N = 138, 24% over 44 years old) had lower values of total carnitine (median value 43 μιηοΐ/l) than male participants with cholesterol above 6.5 mmol/1 (N = 59 median value total carnitine: 47 μπιοΐ/l, ρ < 0.05, 47% over 44 years old).
There was no linear correlation between carnitine and systolic or diastolic blood pressure. No difference of carnitine concentrations was observed between smokers (1 or more cigarettes per day) and non-smokers.
Discussion
Carnitine concentrations obtained in our reference population compared well with the data of most other authors, which were, however, obtained on smaller samples of males and females (8, 9, 14, 17, 18) . Some authors (19) (20) (21) have reported higher total and free carnitine concentrations. As already discussed by Schmidt-Sommerfeld & Penn (19) , the total carnitine concentration might be underestimated, because the calculation of total carnitine is based on free carnitine standards. The reasons for this effect are not clear. It can lead to calculate free carnitine concentrations that are higher than the total carnitine concentration in some samples. In our study, such rare cases were discarded. Total and free carnitine concentrations were higher in males than in females, confirming the previously reported observations (14, 18 -21) . In accordance with some authors (20) we found higher acyl/free ratio in females than in males. We are not aware of any endocrinological data that would explain the lower carnitine concentrations found by us in premenopausal women. This fact and the differences observed on carnitine concentrations with age suggest that sex and age must be considered in studies involving carnitine.
All correlations observed between carnitine fractions and other clinical chemistry quantities, although statistically significant, account only for up to 5% of the total variance and thus can be considered as not clinically relevant. With respect to uric acid, creatinine and albumin, the correlations were probably due to the nutritional state, as fasting was not a prerequisite. These correlations may also reflect a general dietary effect in a well nourished population (22) (23) (24) . Such factors have however been shown not to affect the intraindividual variation of carnitine concentrations (14) . The correlation between total and free carnitine and uric acid has already been observed in undialysed patients with chronic renal insufficiency (11) .
In contrast to data of patients with liver cirrhosis (9), the γ-glutamyl transferase was inversely correlated with the acyl/free ratio in females (not in males) in our healthy ambulatory population.
Our results clearly indicate that when plasma carnitine concentrations are compared in adults, the groups have to be matched at least for sex and, particularly in females, for age.
